Role of osteoglycin in the linkage between muscle and bone

Journal of Biological Chemistry

Volumn 287, Issue 15, 2012, Pages 11616-11628

  Tanaka, Ken Ichiro ^a,b   Matsumoto, Erika ^a   Higashimaki, Yoshiko ^a   Katagiri, Takenobu ^c   Sugimoto, Toshitsugu ^b   Seino, Susumu ^a   Kaji, Hiroshi ^a,d  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; HISTOLOGY; MUSCLE; PHOSPHATASES;

ALKALINE PHOSPHATASE; BONE METABOLISM; BONE MORPHOGENETIC PROTEINS; CONDITIONED MEDIUM; DNA MICROARRAY ANALYSIS; OSTEOBLASTIC CELLS; TRANSCRIPTIONAL ACTIVITY; TYPE I COLLAGEN;

CELLS;

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; OSTEOGLYCIN; PEPTIDE HORMONE; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE; BONE MINERALIZATION; CALVARIA; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE OVEREXPRESSION; HORMONE ACTION; MOUSE; MUSCLE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; OGN GENE; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

EID: 84859489737     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.292193     Document Type: Article

References (53)

1. Capozza, R. F., Cure-Cure, C., Cointry, G. R., Meta, M., Cure, P., Rittweger, J., and Ferretti, J. L. (2008) Association between low lean body mass and osteoporotic fractures after menopause. Menopause 15, 905-913
2. Khosla, S., Atkinson, E. J., Riggs, B. L., and Melton, L. J., 3rd. (1996) Relationship between body composition and bone mass in women. J. Bone Miner Res. 11, 857-863 (Pubitemid 26172811)
3. Nakaoka, D., Sugimoto, T., Kaji, H., Kanzawa, M., Yano, S., Yamauchi, M., Sugishita, T., and Chihara, K. (2001) Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women. Osteoporos Int. 12, 548-554 (Pubitemid 32777430)
4. Bragdon, B., Moseychuk, O., Saldanha, S., King, D., Julian, J., and Nohe, A. (2011) Bone morphogenetic proteins. A critical review. Cell. Signal. 23, 609-620
5. Utvåg, S. E., Grundnes, O., Rindal, D. B., and Reikerås, O. (2003) Influence of extensive muscle injury on fracture healing in rat tibia. J. Orthop. Trauma 17, 430-435
6. Richards, R. R., McKee, M. D., Paitich, C. B., Anderson, G. I., and Bertoia, J. T. (1991) A comparison of the effects of skin coverage and muscle flap coverage on the early strength of union at the site of osteotomy after devascularization of a segment of canine tibia. J. Bone Joint Surg. Am. 73, 1323-1330
7. Glass, G. E., Chan, J. K., Freidin, A., Feldmann, M., Horwood, N. J., and Nanchahal, J. (2011) TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc. Natl. Acad. Sci. U.S.A. 108, 1585-1590
8. Chan, X. C., McDermott, J. C., and Siu, K. W. (2007) Identification of secreted proteins during skeletal muscle development. J. Proteome Res. 6, 698-710 (Pubitemid 46340173)
9. Kaplan, F. S., Le Merrer, M., Glaser, D. L., Pignolo, R. J., Goldsby, R. E., Kitterman, J. A., Groppe, J., and Shore, E. M. (2008) Fibrodysplasia ossificans progressiva. Best Pract. Res. Clin. Rheumatol. 22, 191-205 (Pubitemid 351325734)
10. Shore, E. M., Xu, M., Feldman, G. J., Fenstermacher, D. A., Cho, T. J., Choi, I. H., Connor, J. M., Delai, P., Glaser, D. L., LeMerrer, M., Morhart, R., Rogers, J. G., Smith, R., Triffitt, J. T., Urtizberea, J. A., Zasloff, M., Brown, M. A., and Kaplan, F. S. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 38, 525-527
11. Fukuda, T., Kohda, M., Kanomata, K., Nojima, J., Nakamura, A., Kamizono, J., Noguchi, Y., Iwakiri, K., Kondo, T., Kurose, J., Endo, K., Awakura, T., Fukushi, J., Nakashima, Y., Chiyonobu, T., Kawara, A., Nishida, Y., Wada, I., Akita, M., Komori, T., Nakayama, K., Nanba, A., Maruki, Y., Yoda, T., Tomoda, H., Yu, P. B., Shore, E. M., Kaplan, F. S., Miyazono, K., Matsuoka, M., Ikebuchi, K., Ohtake, A., Oda, H., Jimi, E., Owan, I., Okazaki, Y., and Katagiri, T. (2009) Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J. Biol. Chem. 284, 7149-7156
12. Hisa, I., Inoue, Y., Hendy, G. N., Canaff, L., Kitazawa, R., Kitazawa, S., Komori, T., Sugimoto, T., Seino, S., and Kaji, H. (2011) Parathyroid hormone- responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway. J. Biol. Chem. 286, 9787-9796
13. Sowa, H., Kaji, H., Yamaguchi, T., Sugimoto, T., and Chihara, K. (2002) Activations of ERK1/2 and JNK by transforming growth factor β negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J. Biol. Chem. 277, 36024-36031
14. Sowa, H., Kaji, H., Hendy, G. N., Canaff, L., Komori, T., Sugimoto, T., and Chihara, K. (2004) Menin is required for bone morphogenetic protein 2- and transforming growth factor β-regulated osteoblastic differentiation through interaction with Smads and Runx2. J. Biol. Chem. 279, 40267-40275 (Pubitemid 39287610)
15. Tasheva, E. S., Klocke, B., and Conrad, G. W. (2004) Analysis of transcriptional regulation of the small leucine-rich proteoglycans. Mol. Vis. 10, 758-772 (Pubitemid 41358218)
16. Hildebrand, A., Romarís, M., Rasmussen, L. M., Heinegård, D., Twardzik, D. R., Border, W. A., and Ruoslahti, E. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin, and fibromodulin with transforming growth factor β. Biochem. J. 302, 527-534 (Pubitemid 24280108)
17. Iozzo, R. V. (1998) Matrix proteoglycans. From molecular design to cellular function. Annu. Rev. Biochem. 67, 609-652
18. Balint, E., Lapointe, D., Drissi, H., van der Meijden, C., Young, D. W., van Wijnen, A. J., Stein, J. L., Stein, G. S., and Lian, J. B. (2003) Phenotype discovery by gene expression profiling. Mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J. Cell. Biochem. 89, 401-426 (Pubitemid 36547274)
19. Bentz, H., Nathan, R. M., Rosen, D. M., Armstrong, R. M., Thompson, A. Y., Segarini, P. R., Mathews, M. C., Dasch, J. R., Piez, K. A., and Seyedin, S. M. (1989) Purification and characterization of a unique osteoinductive factor from bovine bone. J. Biol. Chem. 264, 20805-20810 (Pubitemid 20009282)
20. Williamson, R. E., Darrow, K. N., Giersch, A. B., Resendes, B. L., Huang, M., Conrad, G. W., Chen, Z. Y., Liberman, M. C., Morton, C. C., and Tasheva, E. S. (2008) Expression studies of osteoglycin/mimecan (OGN) in the cochlea and auditory phenotype of Ogn-deficient mice. Hear Res. 237, 57-65
21. Osawa, A., Kato, M., Matsumoto, E., Iwase, K., Sugimoto, T., Matsui, T., Ishikura, H., Sugano, S., Kurosawa, H., Takiguchi, M., and Seki, N. (2006) Activation of genes for growth factor and cytokine pathways late in chondrogenic differentiation of ATDC5 cells. Genomics 88, 52-64 (Pubitemid 43851177)
22. Kampmann, A., Fernández, B., Deindl, E., Kubin, T., Pipp, F., Eitenmüller, I., Hoefer, I. E., Schaper, W., and Zimmermann, R. (2009) The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis. Mol. Cell. Biochem. 322, 15-23
23. Cui, X., Song, B., Hou, L., Wei, Z., and Tang, J. (2008) High expression of osteoglycin decreases the metastatic capability of mouse hepatocarcinoma Hca-F cells to lymph nodes. Acta Biochim. Biophys. Sin. 40, 349-355 (Pubitemid 351572116)
24. Cui, X. N., Tang, J. W., Song, B., Wang, B., Chen, S. Y., and Hou, L. (2009) High expression of osteoglycin decreases gelatinase activity of murine hepatocarcinoma Hca-F cells. World J. Gastroenterol 15, 6117-6122
25. Chan, C. Y., Masui, O., Krakovska, O., Belozerov, V. E., Voisin, S., Ghanny, S., Chen, J., Moyez, D., Zhu, P., Evans, K. R., McDermott, J. C., and Siu, K. W. (2011) Identification of differentially regulated secretome components during skeletal myogenesis. Mol. Cell. Proteomics 10, M110.004804
26. Xing, W., Baylink, D., Kesavan, C., Hu, Y., Kapoor, S., Chadwick, R. B., and Mohan, S. (2005) Global gene expression analysis in the bones reveals involvement of several novel genes and pathways in mediating an anabolic response of mechanical loading in mice. J. Cell. Biochem. 96, 1049 -1060
27. Patel, M. J., Liu, W., Sykes, M. C., Ward, N. E., Risin, S. A., Risin, D., and Jo, H. (2007) Identification of mechanosensitive genes in osteoblasts by comparative microarray studies using the rotating wall vessel and the random positioning machine. J. Cell. Biochem. 101, 587-599 (Pubitemid 46698844)
28. Liu, W., Toyosawa, S., Furuichi, T., Kanatani, N., Yoshida, C., Liu, Y., Himeno, M., Narai, S., Yamaguchi, A., and Komori, T. (2001) Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J. Cell Biol. 155, 157-166 (Pubitemid 34286216)
29. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., and Tataranni, P. A. (2001) Hypoadiponectinemia in obesity and type 2 diabetes. Close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930-1935 (Pubitemid 32472900)
30. Tu, Q., Zhang, J., Dong, L. Q., Saunders, E., Luo, E., Tang, J., and Chen, J. (2011) Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J. Biol. Chem. 286, 12542-12553
31. Fantuzzi, G., and Faggioni, R. (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 68, 437-446
32. Kapur, S., Amoui, M., Kesavan, C., Wang, X., Mohan, S., Baylink, D. J., and Lau, K. H. (2010) Leptin receptor (Lepr) is a negative modulator of bone mechanosensitivity, and genetic variations in Lepr may contribute to the differential osteogenic response to mechanical stimulation in the C57BL/6J and C3H/HeJ pair of mouse strains. J. Biol. Chem. 285, 37607-37618
33. Karsenty, G., and Oury, F. (2010) The central regulation of bone mass, and the first link between bone remodeling and energy metabolism. J. Clin. Endocrinol. Metab. 95, 4795-4801
34. Febbraio, M. A., Hiscock, N., Sacchetti, M., Fischer, C. P., and Pedersen, B. K. (2004) Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53, 1643-1648 (Pubitemid 38864744)
35. van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Møller, K., Saltin, B., Febbraio, M. A., and Pedersen, B. K. (2003) Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 88, 3005-3010 (Pubitemid 36877463)
36. Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., Gromada, J., Brozinick, J. T., Hawkins, E. D., Wroblewski, V. J., Li, D. S., Mehrbod, F., Jaskunas, S. R., and Shanafelt, A. B. (2005) FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-1635 (Pubitemid 40814671)
37. Izumiya, Y., Bina, H. A., Ouchi, N., Akasaki, Y., Kharitonenkov, A., and Walsh, K. (2008) FGF21 is an Akt-regulated myokine. FEBS Lett. 582, 3805-3810
38. Pedersen, B. K. (2009) Edward F. Adolph distinguished lecture. Muscle as an endocrine organ. IL-6 and other myokines. J. Appl. Physiol. 107, 1006-1014
39. Pedersen, B. K., Akerström, T. C., Nielsen, A. R., and Fischer, C. P. (2007) Role of myokines in exercise and metabolism. J. Appl. Physiol. 103, 1093-1098 (Pubitemid 47358897)
40. Janssens, K., ten Dijke, P., Janssens, S., and Van Hul, W. (2005) Transforming growth factor-β1 to the bone. Endocr. Rev. 26, 743-774
41. Feng, X. H., and Derynck, R. (2005) Specificity and versatility in TGF-βsignaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693
42. Massagué, J., Seoane, J., and Wotton, D. (2005) Smad transcription factors. Genes Dev. 19, 2783-2810 (Pubitemid 41739965)
43. Sowa, H., Kaji, H., Yamaguchi, T., Sugimoto, T., and Chihara, K. (2002) Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells. J. Bone Miner. Res. 17, 1190-1199 (Pubitemid 34680495)
44. Borton, A. J., Frederick, J. P., Datto, M. B., Wang, X. F., and Weinstein, R. S. (2001) The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J. Bone Miner. Res. 16, 1754-1764 (Pubitemid 32911480)
45. Inoue, Y., Canaff, L., Hendy, G. N., Hisa, I., Sugimoto, T., Chihara, K., and Kaji, H. (2009) Role of Smad3, acting independently of transforming growth factor-β, in the early induction of Wnt-β-catenin signaling by parathyroid hormone in mouse osteoblastic cells. J. Cell. Biochem. 108, 285-294
46. Shanahan, C. M., Cary, N. R., Osbourn, J. K., and Weissberg, P. L. (1997) Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 17, 2437-2447 (Pubitemid 28015979)
47. Tasheva, E. S., Funderburgh, M. L., McReynolds, J., Funderburgh, J. L., and Conrad, G. W. (1999) The bovine mimecan gene. Molecular cloning and characterization of two major RNA transcripts generated by alternative use of two splice acceptor sites in the third exon. J. Biol. Chem. 274, 18693-18701
48. Tasheva, E. S. (2002) Analysis of the promoter region of human mimecan gene. Biochim. Biophys. Acta 1575, 123-129
49. Tasheva, E. S., and Conrad, G. W. (2003) Interferon-γ regulation of the human mimecan promoter. Mol. Vis. 9, 277-287 (Pubitemid 38097597)
50. Ge, G., Seo, N. S., Liang, X., Hopkins, D. R., Höök, M., and Greenspan, D. S. (2004) Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis. J. Biol. Chem. 279, 41626-41633 (Pubitemid 39313606)
51. Tasheva, E. S., Koester, A., Paulsen, A. Q., Garrett, A. S., Boyle, D. L., Davidson, H. J., Song, M., Fox, N., and Conrad, G. W. (2002) Mimecan/ osteoglycin-deficient mice have collagen fibril abnormalities. Mol. Vis. 8, 407-415 (Pubitemid 36153631)
52. Madisen, L., Neubauer, M., Plowman, G., Rosen, D., Segarini, P., Dasch, J., Thompson, A., Ziman, J., Bentz, H., and Purchio, A. F. (1990) Molecular cloning of a novel bone-forming compound. Osteoinductive factor. DNA Cell Biol. 9, 303-309 (Pubitemid 20199472)
53. Beecher, N., Carlson, C., Allen, B. R., Kipchumba, R., Conrad, G. W., Meek, K. M., and Quantock, A. J. (2005) An x-ray diffraction study of corneal structure in mimecan-deficient mice. Invest. Ophthalmol. Vis. Sci. 46, 4046-4049 (Pubitemid 44264603)